Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study

A. Irem Sonmez, M. Utku Kucuker, Charles P. Lewis, Bhanu Prakash Kolla, Deniz Doruk Camsari, Jennifer L. Vande Voort, Kathryn M. Schak, Simon Kung, Paul E. Croarkin

Research output: Contribution to journalArticle

Abstract

Study objectives: Sleep disruption is a significant symptom of major depressive disorder (MDD). To our knowledge, no prior work has examined the impact of repetitive transcranial magnetic stimulation (rTMS) on sleep disturbances in adolescents with MDD. Methods: Seventeen adolescents with treatment-resistant depression received 30 daily sessions of 10-Hz rTMS applied to the left dorsolateral prefrontal cortex (L-DLPFC). Clinical symptoms were assessed at baseline; after 10, 20, and 30 treatments; and at a 6-month follow-up visit. Insomnia was measured with a 3-item subscale of the Quick Inventory of Depressive Symptomatology – Adolescent (17 Item) – Self Report (QIDS-A17-SR). Hypersomnia was measured with a single QIDS-A17-SR item. Depression severity was rated with the Children's Depression Rating Scale, Revised (CDRS-R). The effect of rTMS on sleep was examined via linear mixed model analyses, with fixed effects of time (as a proxy of treatment), depression severity, age, and hypnotic medication use. Results: No significant main effect of time was observed on the insomnia subscale (F4,43.442 = 1.078, p = 0 .379). However, there was a significant main effect of time on the QIDS-A17-SR hypersomnia score (F4,46.124 = 2.733, p = 0 .040), with significant improvement from baseline to treatment 10 (padj = 0.019) and from baseline to 6-month follow-up (padj = 0.044). In exploratory sensitivity analyses, response/nonresponse to rTMS for overall depressive symptoms had no significant effect on sleep outcomes. Conclusions: rTMS may have intrinsic effects on hypersomnia apart from its antidepressant effects in depressed adolescents. Future work should utilize sham controls and objective, quantitative measurements of sleep architecture to assess effects of rTMS in depressed adolescents. Clinical trial registry: Clinicaltrials.gov identifiers are NCT00587639, NCT01502033, NCT01804270.

Original languageEnglish (US)
Article number109763
JournalProgress in Neuro-Psychopharmacology and Biological Psychiatry
Volume97
DOIs
StatePublished - Mar 8 2020

Fingerprint

Disorders of Excessive Somnolence
Transcranial Magnetic Stimulation
Sleep
Self Report
Depression
Major Depressive Disorder
Sleep Initiation and Maintenance Disorders
Equipment and Supplies
Treatment-Resistant Depressive Disorder
Proxy
Prefrontal Cortex
Hypnotics and Sedatives
Antidepressive Agents
Registries
Linear Models
Therapeutics
Clinical Trials

Keywords

  • Adolescent
  • Depression
  • Hypersomnia
  • Insomnia
  • Repetitive transcranial magnetic stimulation (rTMS)

ASJC Scopus subject areas

  • Pharmacology
  • Biological Psychiatry

Cite this

Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents : Preliminary evidence from an open-label study. / Sonmez, A. Irem; Kucuker, M. Utku; Lewis, Charles P.; Kolla, Bhanu Prakash; Doruk Camsari, Deniz; Vande Voort, Jennifer L.; Schak, Kathryn M.; Kung, Simon; Croarkin, Paul E.

In: Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 97, 109763, 08.03.2020.

Research output: Contribution to journalArticle

@article{fa01f607432949f6b29fef946a62e092,
title = "Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents: Preliminary evidence from an open-label study",
abstract = "Study objectives: Sleep disruption is a significant symptom of major depressive disorder (MDD). To our knowledge, no prior work has examined the impact of repetitive transcranial magnetic stimulation (rTMS) on sleep disturbances in adolescents with MDD. Methods: Seventeen adolescents with treatment-resistant depression received 30 daily sessions of 10-Hz rTMS applied to the left dorsolateral prefrontal cortex (L-DLPFC). Clinical symptoms were assessed at baseline; after 10, 20, and 30 treatments; and at a 6-month follow-up visit. Insomnia was measured with a 3-item subscale of the Quick Inventory of Depressive Symptomatology – Adolescent (17 Item) – Self Report (QIDS-A17-SR). Hypersomnia was measured with a single QIDS-A17-SR item. Depression severity was rated with the Children's Depression Rating Scale, Revised (CDRS-R). The effect of rTMS on sleep was examined via linear mixed model analyses, with fixed effects of time (as a proxy of treatment), depression severity, age, and hypnotic medication use. Results: No significant main effect of time was observed on the insomnia subscale (F4,43.442 = 1.078, p = 0 .379). However, there was a significant main effect of time on the QIDS-A17-SR hypersomnia score (F4,46.124 = 2.733, p = 0 .040), with significant improvement from baseline to treatment 10 (padj = 0.019) and from baseline to 6-month follow-up (padj = 0.044). In exploratory sensitivity analyses, response/nonresponse to rTMS for overall depressive symptoms had no significant effect on sleep outcomes. Conclusions: rTMS may have intrinsic effects on hypersomnia apart from its antidepressant effects in depressed adolescents. Future work should utilize sham controls and objective, quantitative measurements of sleep architecture to assess effects of rTMS in depressed adolescents. Clinical trial registry: Clinicaltrials.gov identifiers are NCT00587639, NCT01502033, NCT01804270.",
keywords = "Adolescent, Depression, Hypersomnia, Insomnia, Repetitive transcranial magnetic stimulation (rTMS)",
author = "Sonmez, {A. Irem} and Kucuker, {M. Utku} and Lewis, {Charles P.} and Kolla, {Bhanu Prakash} and {Doruk Camsari}, Deniz and {Vande Voort}, {Jennifer L.} and Schak, {Kathryn M.} and Simon Kung and Croarkin, {Paul E.}",
year = "2020",
month = "3",
day = "8",
doi = "10.1016/j.pnpbp.2019.109763",
language = "English (US)",
volume = "97",
journal = "Progress in Neuro-Psychopharmacology and Biological Psychiatry",
issn = "0278-5846",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Improvement in hypersomnia with high frequency repetitive transcranial magnetic stimulation in depressed adolescents

T2 - Preliminary evidence from an open-label study

AU - Sonmez, A. Irem

AU - Kucuker, M. Utku

AU - Lewis, Charles P.

AU - Kolla, Bhanu Prakash

AU - Doruk Camsari, Deniz

AU - Vande Voort, Jennifer L.

AU - Schak, Kathryn M.

AU - Kung, Simon

AU - Croarkin, Paul E.

PY - 2020/3/8

Y1 - 2020/3/8

N2 - Study objectives: Sleep disruption is a significant symptom of major depressive disorder (MDD). To our knowledge, no prior work has examined the impact of repetitive transcranial magnetic stimulation (rTMS) on sleep disturbances in adolescents with MDD. Methods: Seventeen adolescents with treatment-resistant depression received 30 daily sessions of 10-Hz rTMS applied to the left dorsolateral prefrontal cortex (L-DLPFC). Clinical symptoms were assessed at baseline; after 10, 20, and 30 treatments; and at a 6-month follow-up visit. Insomnia was measured with a 3-item subscale of the Quick Inventory of Depressive Symptomatology – Adolescent (17 Item) – Self Report (QIDS-A17-SR). Hypersomnia was measured with a single QIDS-A17-SR item. Depression severity was rated with the Children's Depression Rating Scale, Revised (CDRS-R). The effect of rTMS on sleep was examined via linear mixed model analyses, with fixed effects of time (as a proxy of treatment), depression severity, age, and hypnotic medication use. Results: No significant main effect of time was observed on the insomnia subscale (F4,43.442 = 1.078, p = 0 .379). However, there was a significant main effect of time on the QIDS-A17-SR hypersomnia score (F4,46.124 = 2.733, p = 0 .040), with significant improvement from baseline to treatment 10 (padj = 0.019) and from baseline to 6-month follow-up (padj = 0.044). In exploratory sensitivity analyses, response/nonresponse to rTMS for overall depressive symptoms had no significant effect on sleep outcomes. Conclusions: rTMS may have intrinsic effects on hypersomnia apart from its antidepressant effects in depressed adolescents. Future work should utilize sham controls and objective, quantitative measurements of sleep architecture to assess effects of rTMS in depressed adolescents. Clinical trial registry: Clinicaltrials.gov identifiers are NCT00587639, NCT01502033, NCT01804270.

AB - Study objectives: Sleep disruption is a significant symptom of major depressive disorder (MDD). To our knowledge, no prior work has examined the impact of repetitive transcranial magnetic stimulation (rTMS) on sleep disturbances in adolescents with MDD. Methods: Seventeen adolescents with treatment-resistant depression received 30 daily sessions of 10-Hz rTMS applied to the left dorsolateral prefrontal cortex (L-DLPFC). Clinical symptoms were assessed at baseline; after 10, 20, and 30 treatments; and at a 6-month follow-up visit. Insomnia was measured with a 3-item subscale of the Quick Inventory of Depressive Symptomatology – Adolescent (17 Item) – Self Report (QIDS-A17-SR). Hypersomnia was measured with a single QIDS-A17-SR item. Depression severity was rated with the Children's Depression Rating Scale, Revised (CDRS-R). The effect of rTMS on sleep was examined via linear mixed model analyses, with fixed effects of time (as a proxy of treatment), depression severity, age, and hypnotic medication use. Results: No significant main effect of time was observed on the insomnia subscale (F4,43.442 = 1.078, p = 0 .379). However, there was a significant main effect of time on the QIDS-A17-SR hypersomnia score (F4,46.124 = 2.733, p = 0 .040), with significant improvement from baseline to treatment 10 (padj = 0.019) and from baseline to 6-month follow-up (padj = 0.044). In exploratory sensitivity analyses, response/nonresponse to rTMS for overall depressive symptoms had no significant effect on sleep outcomes. Conclusions: rTMS may have intrinsic effects on hypersomnia apart from its antidepressant effects in depressed adolescents. Future work should utilize sham controls and objective, quantitative measurements of sleep architecture to assess effects of rTMS in depressed adolescents. Clinical trial registry: Clinicaltrials.gov identifiers are NCT00587639, NCT01502033, NCT01804270.

KW - Adolescent

KW - Depression

KW - Hypersomnia

KW - Insomnia

KW - Repetitive transcranial magnetic stimulation (rTMS)

UR - http://www.scopus.com/inward/record.url?scp=85074061262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074061262&partnerID=8YFLogxK

U2 - 10.1016/j.pnpbp.2019.109763

DO - 10.1016/j.pnpbp.2019.109763

M3 - Article

C2 - 31634515

AN - SCOPUS:85074061262

VL - 97

JO - Progress in Neuro-Psychopharmacology and Biological Psychiatry

JF - Progress in Neuro-Psychopharmacology and Biological Psychiatry

SN - 0278-5846

M1 - 109763

ER -